Next Event

@Campus Biotech (Geneva), Oct 25th


Tax Planning and Incentive Models for Life Sciences companies


8h00 - 8h30: Networking Breakfast


8h30 - 8h40: Welcoming words, EY


8h40 - 9h00: IP planning and R&D activities in light of the Swiss Corporate Tax Reform III

Christian Aivazian, Executive Director, Corporate Tax, EY


9h00 - 9h20: IP planning and R&D activities in light of BEPS by Peter Dörrfuß, Partner, Life Sciences Leader Tax, EY


9h20 -9h40: Roundtable discussion and Q&As with all speakers

Given the new international standards on corporate taxation, Switzerland is currently undergoing a major corporate tax reform to remain an attractive business location.


In this context, Life Sciences companies will be impacted by OECD’s work on Base Erosion and Profit Shifting (BEPS) and the Swiss Corporate Tax Reform III for their IP planning and R&D activities.


The Speakers will present and discuss the new requirements and opportunities from a tax standpoint. As usual, this C-Suite will be a mixture of short talks, lively roundtable and networking opportunities dedicated to a selective CXOs audience.